Agios Pharmaceuticals, Inc.
Clinical trials sponsored by Agios Pharmaceuticals, Inc., explained in plain language.
-
New drug trial aims to boost blood health in sickle cell patients
Disease control Recruiting nowThis study is testing an investigational drug called tebapivat to see if it can improve anemia in people with sickle cell disease. About 56 participants will be randomly assigned to receive either tebapivat or a placebo (an inactive substance) to compare their effects. The main g…
Phase: PHASE2 • Sponsor: Agios Pharmaceuticals, Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
First human test for new drug begins
Knowledge-focused Recruiting nowThis is the first study in people for a new drug called AG-236. Its main goal is to check if a single injection is safe and well-tolerated in healthy volunteers. Researchers will also measure how the drug moves through and leaves the body. The results will help decide if AG-236 c…
Phase: PHASE1 • Sponsor: Agios Pharmaceuticals, Inc. • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:33 UTC